Global CGRP Antagonists Market Research Report 2026(Status and Outlook)
Description
Report Overview
CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
The global CGRP Antagonists market size was estimated at USD 4077.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 20.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CGRP Antagonists market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CGRP Antagonists market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CGRP Antagonists market.
Global CGRP Antagonists Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
PFIZER INC(Biohaven)
ABBVIE INC
Amgen
Teva
Eli Lilly and Company
Lundbeck
Novartis
Market Segmentation (by Type)
Monoclonal Antibodies
CGRP Receptor Inhibitor
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CGRP Antagonists Market
Overview of the regional outlook of the CGRP Antagonists Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CGRP Antagonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CGRP Antagonists, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
The global CGRP Antagonists market size was estimated at USD 4077.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 20.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CGRP Antagonists market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CGRP Antagonists market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CGRP Antagonists market.
Global CGRP Antagonists Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
PFIZER INC(Biohaven)
ABBVIE INC
Amgen
Teva
Eli Lilly and Company
Lundbeck
Novartis
Market Segmentation (by Type)
Monoclonal Antibodies
CGRP Receptor Inhibitor
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CGRP Antagonists Market
Overview of the regional outlook of the CGRP Antagonists Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CGRP Antagonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CGRP Antagonists, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
130 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of CGRP Antagonists
- 1.2 Key Market Segments
- 1.2.1 CGRP Antagonists Segment by Type
- 1.2.2 CGRP Antagonists Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 CGRP Antagonists Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global CGRP Antagonists Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global CGRP Antagonists Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 CGRP Antagonists Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global CGRP Antagonists Product Life Cycle
- 3.3 Global CGRP Antagonists Sales by Manufacturers (2020-2025)
- 3.4 Global CGRP Antagonists Revenue Market Share by Manufacturers (2020-2025)
- 3.5 CGRP Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global CGRP Antagonists Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 CGRP Antagonists Market Competitive Situation and Trends
- 3.8.1 CGRP Antagonists Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest CGRP Antagonists Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 CGRP Antagonists Industry Chain Analysis
- 4.1 CGRP Antagonists Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of CGRP Antagonists Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global CGRP Antagonists Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to CGRP Antagonists Market
- 5.7 ESG Ratings of Leading Companies
- 6 CGRP Antagonists Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global CGRP Antagonists Sales Market Share by Type (2020-2025)
- 6.3 Global CGRP Antagonists Market Size by Type (2020-2025)
- 6.4 Global CGRP Antagonists Price by Type (2020-2025)
- 7 CGRP Antagonists Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global CGRP Antagonists Market Sales by Application (2020-2025)
- 7.3 Global CGRP Antagonists Market Size (M USD) by Application (2020-2025)
- 7.4 Global CGRP Antagonists Sales Growth Rate by Application (2020-2025)
- 8 CGRP Antagonists Market Sales by Region
- 8.1 Global CGRP Antagonists Sales by Region
- 8.1.1 Global CGRP Antagonists Sales by Region
- 8.1.2 Global CGRP Antagonists Sales Market Share by Region
- 8.2 Global CGRP Antagonists Market Size by Region
- 8.2.1 Global CGRP Antagonists Market Size by Region
- 8.2.2 Global CGRP Antagonists Market Size by Region
- 8.3 North America
- 8.3.1 North America CGRP Antagonists Sales by Country
- 8.3.2 North America CGRP Antagonists Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe CGRP Antagonists Sales by Country
- 8.4.2 Europe CGRP Antagonists Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific CGRP Antagonists Sales by Region
- 8.5.2 Asia Pacific CGRP Antagonists Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America CGRP Antagonists Sales by Country
- 8.6.2 South America CGRP Antagonists Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa CGRP Antagonists Sales by Region
- 8.7.2 Middle East and Africa CGRP Antagonists Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 CGRP Antagonists Market Production by Region
- 9.1 Global Production of CGRP Antagonists by Region(2020-2025)
- 9.2 Global CGRP Antagonists Revenue Market Share by Region (2020-2025)
- 9.3 Global CGRP Antagonists Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America CGRP Antagonists Production
- 9.4.1 North America CGRP Antagonists Production Growth Rate (2020-2025)
- 9.4.2 North America CGRP Antagonists Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe CGRP Antagonists Production
- 9.5.1 Europe CGRP Antagonists Production Growth Rate (2020-2025)
- 9.5.2 Europe CGRP Antagonists Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan CGRP Antagonists Production (2020-2025)
- 9.6.1 Japan CGRP Antagonists Production Growth Rate (2020-2025)
- 9.6.2 Japan CGRP Antagonists Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China CGRP Antagonists Production (2020-2025)
- 9.7.1 China CGRP Antagonists Production Growth Rate (2020-2025)
- 9.7.2 China CGRP Antagonists Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 PFIZER INC(Biohaven)
- 10.1.1 PFIZER INC(Biohaven) Basic Information
- 10.1.2 PFIZER INC(Biohaven) CGRP Antagonists Product Overview
- 10.1.3 PFIZER INC(Biohaven) CGRP Antagonists Product Market Performance
- 10.1.4 PFIZER INC(Biohaven) Business Overview
- 10.1.5 PFIZER INC(Biohaven) SWOT Analysis
- 10.1.6 PFIZER INC(Biohaven) Recent Developments
- 10.2 ABBVIE INC
- 10.2.1 ABBVIE INC Basic Information
- 10.2.2 ABBVIE INC CGRP Antagonists Product Overview
- 10.2.3 ABBVIE INC CGRP Antagonists Product Market Performance
- 10.2.4 ABBVIE INC Business Overview
- 10.2.5 ABBVIE INC SWOT Analysis
- 10.2.6 ABBVIE INC Recent Developments
- 10.3 Amgen
- 10.3.1 Amgen Basic Information
- 10.3.2 Amgen CGRP Antagonists Product Overview
- 10.3.3 Amgen CGRP Antagonists Product Market Performance
- 10.3.4 Amgen Business Overview
- 10.3.5 Amgen SWOT Analysis
- 10.3.6 Amgen Recent Developments
- 10.4 Teva
- 10.4.1 Teva Basic Information
- 10.4.2 Teva CGRP Antagonists Product Overview
- 10.4.3 Teva CGRP Antagonists Product Market Performance
- 10.4.4 Teva Business Overview
- 10.4.5 Teva Recent Developments
- 10.5 Eli Lilly and Company
- 10.5.1 Eli Lilly and Company Basic Information
- 10.5.2 Eli Lilly and Company CGRP Antagonists Product Overview
- 10.5.3 Eli Lilly and Company CGRP Antagonists Product Market Performance
- 10.5.4 Eli Lilly and Company Business Overview
- 10.5.5 Eli Lilly and Company Recent Developments
- 10.6 Lundbeck
- 10.6.1 Lundbeck Basic Information
- 10.6.2 Lundbeck CGRP Antagonists Product Overview
- 10.6.3 Lundbeck CGRP Antagonists Product Market Performance
- 10.6.4 Lundbeck Business Overview
- 10.6.5 Lundbeck Recent Developments
- 10.7 Novartis
- 10.7.1 Novartis Basic Information
- 10.7.2 Novartis CGRP Antagonists Product Overview
- 10.7.3 Novartis CGRP Antagonists Product Market Performance
- 10.7.4 Novartis Business Overview
- 10.7.5 Novartis Recent Developments
- 11 CGRP Antagonists Market Forecast by Region
- 11.1 Global CGRP Antagonists Market Size Forecast
- 11.2 Global CGRP Antagonists Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe CGRP Antagonists Market Size Forecast by Country
- 11.2.3 Asia Pacific CGRP Antagonists Market Size Forecast by Region
- 11.2.4 South America CGRP Antagonists Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of CGRP Antagonists by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global CGRP Antagonists Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of CGRP Antagonists by Type (2026-2035)
- 12.1.2 Global CGRP Antagonists Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of CGRP Antagonists by Type (2026-2035)
- 12.2 Global CGRP Antagonists Market Forecast by Application (2026-2035)
- 12.2.1 Global CGRP Antagonists Sales (K MT) Forecast by Application
- 12.2.2 Global CGRP Antagonists Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
